References
- HorstmanAMDillonELUrbanRJSheffield-MooreMThe role of androgens and estrogens on healthy aging and longevityJ Gerontol A Biol Sci Med Sci201267 11 1140 1152 3636678 https://doi.org/10.1093/gerona/gls068 22451474
- ChenJKimJDaltonJTDiscovery and therapeutic promise of selective androgen receptor modulatorsMol Interv20055 3 173 188 2072877 1:CAS:528:DC%2BD2MXmvVakt7w%3D https://doi.org/10.1124/mi.5.3.7 15994457
- Moverare-SkrticSVenkenKAnderssonNLindbergMKSvenssonJSwansonCVanderschuerenDOscarssonJGustafssonJAOhlssonCDihydrotestosterone treatment results in obesity and altered lipid metabolism in orchidectomized miceObesity (Silver Spring)200614 4 662 672 1:CAS:528:DC%2BD28XmsVSmtL8%3D https://doi.org/10.1038/oby.2006.75
- WangCSwerdloffRSShould the nonaromatizable androgen dihydrotestosterone be considered as an alternative to testosterone in the treatment of the andropause?J Clin Endocrinol Metab200287 4 1462 1466 1:CAS:528:DC%2BD38XivFKlsbs%3D https://doi.org/10.1210/jcem.87.4.8488 11932265
- HongBSAhnTYRecent trends in the treatment of testosterone deficiency syndromeInt J Urol200714 11 981 985 1:CAS:528:DC%2BD1cXjs1WmtA%3D%3D https://doi.org/10.1111/j.1442-2042.2007.01882.x 17956520
- SmithASarcopenia, malnutrition and nutrient density in older peoplePost Reprod Health201420 1 19 21 https://doi.org/10.1177/1754045314521552 24879776
- BuvatJMaggiMGuayATorresLOTestosterone deficiency in men: systematic review and standard operating procedures for diagnosis and treatmentJ Sex Med201310 1 245 284 1:CAS:528:DC%2BC3sXisVGhtrg%3D https://doi.org/10.1111/j.1743-6109.2012.02783.x 22971200
- TraishAM5alpha-Reductases in human physiology: an unfolding storyEndocr Pract201218 6 965 975 https://doi.org/10.4158/EP12108.RA 23246684
- BassilNAlkaadeSMorleyJEThe benefits and risks of testosterone replacement therapy: a reviewTher Clin Risk Manag20095 3 427 448 2701485 1:CAS:528:DC%2BD1MXpt1yltbw%3D 19707253
- IssaSADagresEIntraoperative floppy-iris syndrome and finasteride intakeJ Cataract Refract Surg200733 12 2142 2143 https://doi.org/10.1016/j.jcrs.2007.07.025 18053919
- ModlinskiRFieldsKBThe effect of anabolic steroids on the gastrointestinal system, kidneys, and adrenal glandsCurr Sports Med Rep20065 2 104 109 https://doi.org/10.1097/01.CSMR.0000306529.74500.f6 16529682
- Rahimi-ArdabiliBPourandarjaniRHabibollahiPMualekiAFinasteride induced depression: a prospective study. BMC Clin Pharmacol 2006, 6:7BMC Clin Pharmacol20066 7 1622749 https://doi.org/10.1186/1472-6904-6-7 17026771
- VelazquezIAlterBPAndrogens and liver tumors: Fanconi’s anemia and non-Fanconi's conditionsAm J Hematol200477 3 257 267 https://doi.org/10.1002/ajh.20183 15495253
- WongACMakSTFinasteride-associated cataract and intraoperative floppy-iris syndromeJ Cataract Refract Surg201137 7 1351 1354 https://doi.org/10.1016/j.jcrs.2011.04.013 21555201
- BirznieceVSutantoSHoKKGender difference in the neuroendocrine regulation of growth hormone axis by selective estrogen receptor modulatorsJ Clin Endocrinol Metab201297 4 E521 E527 1:CAS:528:DC%2BC38Xlslynsbw%3D https://doi.org/10.1210/jc.2011-3347 22319035
- OsterbergECBernieAMRamasamyRRisks of testosterone replacement therapy in menIndian J Urol201430 1 2 7 3897047 https://doi.org/10.4103/0970-1591.124197 24497673
- YuanJPPengJYinKWangJHPotential health-promoting effects of astaxanthin: a high-value carotenoid mostly from microalgaeMol Nutr Food Res201155 1 150 165 1:CAS:528:DC%2BC3MXpvVSj https://doi.org/10.1002/mnfr.201000414 21207519
- AndersonMLA preliminary investigation of the enzymatic inhibition of 5alpha-reduction and growth of prostatic carcinoma cell line LNCap-FGC by natural astaxanthin and Saw Palmetto lipid extract in vitroJ Herb Pharmacother20055 1 17 26 1:CAS:528:DC%2BD2MXhtFGrsbzL https://doi.org/10.1080/J157v05n01_03 16093232
- AngwaforFAndersonMLAn open label, dose response study to determine the effect of a dietary supplement on dihydrotestosterone, testosterone and estradiol levels in healthy malesJ Int Soc Sports Nutr20085 12 2525623 https://doi.org/10.1186/1550-2783-5-12 18700016
- BainJTestosterone and the aging male: to treat or not to treat?Maturitas201066 1 16 22 1:CAS:528:DC%2BC3cXkvFKlsLo%3D https://doi.org/10.1016/j.maturitas.2010.01.009 20153946
- BjorntorpPEndocrine abnormalities of obesityMetabolism199544 Suppl 3 21 23 1:STN:280:DyaK2MvgsFamsg%3D%3D https://doi.org/10.1016/0026-0495(95)90315-1 7674912
- IsidoriAMCaprioMStrolloFMorettiCFrajeseGIsidoriFFabbriALeptin and androgens in male obesity: Evidence for leptin contribution to reduced androgen levelsJ Clin Endocrinol Metabol199984 10 3673 3680 1:CAS:528:DyaK1MXms1Ohtbg%3D
- TchernofADespresJPBelangerADupontAPrud'hommeDMoorjaniSLupienPJLabrieFReduced testosterone and adrenal C19 steroid levels in obese menMetabolism199544 513 519 1:CAS:528:DyaK2MXltVersrg%3D https://doi.org/10.1016/0026-0495(95)90060-8 7723675
- VermeulenADecreased androgen levels and obesity in menAnn Med199628 13 15 1:CAS:528:DyaK28XjtVGku78%3D https://doi.org/10.3109/07853899608999068 8932500
- PorterRS The Merck Manual of Medical Information2011 New Jersey Merck & Co., Inc